With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
HIV/AIDS, population and reproductive health, women's health, social science methods and public health research, India, South and Southeast Asia, Sub-Saharan Africa
Nandini Oomman was director of the HIV/AIDS Monitor at the Center for Global Development from March 2006 until December 2011. As director, Oomman led three research teams in Uganda, Mozambique, and Zambia to track the effectiveness of the three main aid responses to the epidemic: the Global Fund, the HIV/AIDS Africa MAP program of the World Bank, and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). This collaborative initiative, the first of its kind at CGD, allowed country-based researchers to examine key issues in the design, delivery and management of these donor programs, and provided timely analyses to improve the efficiency and effectiveness of each initiative.
Oomman, N. & J. Gittelsohn. (2002) Qualitative Methods in Gynecological Morbidity Research, in Research Approaches to the Study of Reproductive tract Infections and Other Gynaecological Disorders (eds. Shireen J Jejeebhoy, Michael A Koenig and Christopher Elias). Cambridge University Press, Cambridge UK
Oomman, N. (2000) Gynecological Morbidity in India: A Decade of Research on Reproductive Tract Infections (RTIs) and other Gynaecological Morbidity in India: What we know and what we don’t know, In Readings in Women’s Reproductive Health in India, (eds. R. Ramasubban, & S. Jejeebhoy). Centre for Social and Technological Change, Rawat Publications, Mumbai, India.
Oomman N, & B. Ganatra. (2002) Sex Selection: The Systematic Elimination of Girls Reproductive Health Matters, 10 (19): 184-188
UN Secretary-General Ban Ki-moon yesterday named former Chilean president Michelle Bachelet to head UN Women (full name: UN Entity for Gender Equality and the Empowerment of Women), a new UN entity. Congratulations to Dr. Bachelet!
While the selection process was criticized for lacking openness and transparency, I hope that those of us, like me, who have been awaiting this appointment will put that concern behind us and let her get on with the job. In many ways, Michelle Bachelet is the ideal candidate, with the right credentials to make this important new entity function effectively:
I recently had the opportunity to sit in on a meeting between donor and high-level Ministry of Health representatives in an African country. In a white-washed public health center with high ceiling fans whirring the tension-filled air, I witnessed a scenario that sadly demonstrated that country ownership and the process of re-thinking global health partnerships is perhaps a long way off. The donors were irate that some money they had given to a common fund had been misappropriated, and they wanted to pull all of their money out. The ministry officials who had survived the scandal were frustrated. In their view, they had done well to identify and fire the accused--they felt that the ministry should get credit that their system works to catch corrupt officials. Not a new story, but one that got me thinking about how findings from the HIV/AIDS Monitor’s research in Mozambique, Uganda and Zambia could shed some light on the issue of country ownership in the context of new U.S. global health priorities.
Nandini Oomman recently joined CGD as director of the HIV/AIDS Monitor initiative, which tracks the aid effectiveness of the three biggest donor responses to the epidemic: the Global Fund, PEPFAR, and the World Bank. She brings to the task a wealth of public health policy, research and practical experience that includes managing an HIV/AIDS prevention program for sex workers and college youth in Mumbai, India. In this short Q&A, Oomman describes the purpose and approach of the HIV/AIDS Monitor.
Chris Elias, President & CEO at PATH, will step down from his current position and join the Bill & Melinda Gates Foundation (BMGF) as President for global DEVELOPMENT in February 2012. Yes, that’s global development, not global health. First reactions from many in global health lamented the "loss" of one of the field’s most accomplished and visible experts. But as we digested the details of the announcement and discussed its implications, we realized that the Foundation’s decision could be a bonanza for global health. Here are two reasons why:
The current economic crisis is forcing HIV/AIDS donors to do more with less. Taking on gender inequality in more than a token way to improve efficiency and effectiveness is a no brainer. The current U.S. administration has made women and girls a high priority so PEPFAR has all the political backing it needs, and multi-lateral donors like the Global Fund and the World Bank also have full support from their boards of directors. The powerful combination of budget squeeze and political commitment creates an opportunity for three of the largest HIV/AIDS donors to become the lead "gender bender" in global development; that is, to support development programs that transform the lives of women and girls, and thus the societies in which they live.
WASHINGTON,D.C.(August 4,2008)- Billions of dollars in donor money being spent in developing countries to fight HIV/AIDS can be much more effective if the big donor programs pay more attention to their effects on the health systems of host countries, according to a new report from the Center for Global Development (CGD).